{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T12:55:32Z","timestamp":1788612932188,"version":"build-2803163510"},"reference-count":110,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2013,1,15]],"date-time":"2013-01-15T00:00:00Z","timestamp":1358208000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2013,3]]},"DOI":"10.1007\/s00277-012-1671-3","type":"journal-article","created":{"date-parts":[[2013,1,14]],"date-time":"2013-01-14T06:39:09Z","timestamp":1358145549000},"page":"289-299","source":"Crossref","is-referenced-by-count":23,"title":["Hydroxyurea treatment in \u03b2-thalassemia patients: to respond or not to respond?"],"prefix":"10.1007","volume":"92","author":[{"given":"Mehdi","family":"Banan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,1,15]]},"reference":[{"key":"1671_CR1","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1017\/CBO9780511596582.007","volume-title":"Disorders of hemoglobin","author":"BG Forget","year":"2009","unstructured":"Forget BG, Hardison RC (2009) The normal structure and regulation of human globin gene clusters. In: Steinberg MH, Forget BG, Higgs DR, Weatherall DJ (eds) Disorders of hemoglobin, 2nd edn. Cambridge University Press, New York, pp 46\u201361","edition":"2"},{"issue":"6","key":"1671_CR2","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1172\/JCI25398","volume":"115","author":"A Bank","year":"2005","unstructured":"Bank A (2005) Understanding globin regulation in \u03b2-thalassemia: it\u2019s as simple as \u03b1, \u03b2, \u03b3, \u03b4. J Clin Invest 115(6):1470\u20131473","journal-title":"J Clin Invest"},{"issue":"2","key":"1671_CR3","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1182\/blood-2005-05-2113","volume":"107","author":"A Bank","year":"2006","unstructured":"Bank A (2006) Regulation of human fetal hemoglobin: new players, new complexities. Blood 107(2):435\u2013443","journal-title":"Blood"},{"key":"1671_CR4","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1017\/CBO9780511596582.009","volume-title":"Disorders of hemoglobin","author":"G Stamatoyannopoulos","year":"2009","unstructured":"Stamatoyannopoulos G, Navas PA, Li Q (2009) Molecular and cellular basis of hemoglobin switching. In: Steinberg MH, Forget BG, Higgs DR, Weatherall DJ (eds) Disorders of hemoglobin, 2nd edn. Cambridge University Press, New York, pp 86\u2013100","edition":"2"},{"issue":"11","key":"1671_CR5","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1056\/NEJMra050436","volume":"353","author":"D Rund","year":"2005","unstructured":"Rund D, Rachmilewitz E (2005) \u03b2-thalassemia. N Engl J Med 353(11):1135\u20131146","journal-title":"N Engl J Med"},{"key":"1671_CR6","doi-asserted-by":"crossref","unstructured":"Weatherall D (2001) Thalassemias. In: Encyclopedia of Life Sciences. Wiley, Chichester","DOI":"10.1006\/rwgn.2001.1286"},{"key":"1671_CR7","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1017\/CBO9780511596582.023","volume-title":"Disorders of hemoglobin","author":"SL Thein","year":"2009","unstructured":"Thein SL, Wood WG (2009) The molecular basis of \u03b2 thalassemia, \u03b4\u03b2 thalassemia, and hereditary persistence of fetal hemoglobin. In: Steinberg MH, Forget BG, Higgs DR, Weatherall DJ (eds) Disorders of hemoglobin, 2nd edn. Cambridge University Press, Cambridge, pp 323\u2013356","edition":"2"},{"issue":"4","key":"1671_CR8","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1038\/35066048","volume":"2","author":"DJ Weatherall","year":"2001","unstructured":"Weatherall DJ (2001) Phenotype-genotype relationships in monogenic disease: lessons from the thalassaemias. Nat Rev Genet 2(4):245\u2013255","journal-title":"Nat Rev Genet"},{"issue":"5","key":"1671_CR9","first-page":"649","volume":"90","author":"SL Thein","year":"2005","unstructured":"Thein SL (2005) Genetic modifiers of \u03b2-thalassemia. Haematologica 90(5):649\u2013660","journal-title":"Haematologica"},{"issue":"5","key":"1671_CR10","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1002\/humu.20225","volume":"26","author":"GP Patrinos","year":"2005","unstructured":"Patrinos GP, Kollia P, Papadakis MN (2005) Molecular diagnosis of inherited disorders: lessons from hemoglobinopathies. Hum Mutat 26(5):399\u2013412","journal-title":"Hum Mutat"},{"issue":"1","key":"1671_CR11","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1182\/asheducation-2005.1.38","volume":"2005","author":"SP Perrine","year":"2005","unstructured":"Perrine SP (2005) Fetal globin induction: can it cure \u03b2 thalassemia? Hematology 2005(1):38\u201344","journal-title":"Hematology"},{"issue":"17","key":"1671_CR12","doi-asserted-by":"crossref","first-page":"10256","DOI":"10.1074\/jbc.270.17.10256","volume":"270","author":"NP Anagnou","year":"1995","unstructured":"Anagnou NP, Perez-Stable C, Gelinas R, Costantini F, Liapaki K, Constantopoulou M, Kosteas T, Moschonas NK, George S (1995) Sequences located 3\u2032 to the breakpoint of the hereditary persistence of fetal hemoglobin-3 deletion exhibit enhancer activity and can modify the developmental expression of the human fetal A\u03b3-globin gene in transgenic mice. J Biol Chem 270(17):10256\u201310263","journal-title":"J Biol Chem"},{"issue":"4","key":"1671_CR13","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1128\/MCB.10.4.1382","volume":"10","author":"JT Elder","year":"1990","unstructured":"Elder JT, Forrester WC, Thompson C, Mager D, Henthorn P, Peretz M, Papayannopoulou T, Groudine M (1990) Translocation of an erythroid-specific hypersensitive site in deletion-type hereditary persistence of fetal hemoglobin. Mol Cell Biol 10(4):1382\u20131389","journal-title":"Mol Cell Biol"},{"issue":"20","key":"1671_CR14","doi-asserted-by":"crossref","first-page":"3047","DOI":"10.1093\/hmg\/ddi337","volume":"14","author":"P Xiang","year":"2005","unstructured":"Xiang P, Han H, Barkess G, Olave I, Fang X, Yin W, Stamatoyannopoulos G, Li Q (2005) Juxtaposition of the HPFH2 enhancer is not sufficient to reactivate the \u03b3-globin gene in adult erythropoiesis. Hum Mol Genet 14(20):3047\u20133056","journal-title":"Hum Mol Genet"},{"issue":"9","key":"1671_CR15","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1056\/NEJMoa1103070","volume":"365","author":"VG Sankaran","year":"2011","unstructured":"Sankaran VG, Xu J, Byron R, Greisman HA, Fisher C, Weatherall DJ, Sabath DE, Groudine M, Orkin SH, Premawardhena A, Bender MA (2011) A functional element necessary for fetal hemoglobin silencing. N Engl J Med 365(9):807\u2013814","journal-title":"N Engl J Med"},{"key":"1671_CR16","doi-asserted-by":"crossref","unstructured":"Ghedira ES, Lecerf L, Faubert E, Coste B, Moradkhani K, Bachir D, Galacteros F, Pissard S (2013) Estimation of the difference in HbF expression due to loss of the 5\u2032 \u03b4-globin BCL11A binding region. Haematologica (in press)","DOI":"10.3324\/haematol.2012.061994"},{"issue":"6","key":"1671_CR17","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1007\/s00277-008-0637-y","volume":"88","author":"U Testa","year":"2009","unstructured":"Testa U (2009) Fetal hemoglobin chemical inducers for treatment of hemoglobinopathies. Ann Hematol 88(6):505\u2013528","journal-title":"Ann Hematol"},{"issue":"1","key":"1671_CR18","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1182\/asheducation-2003.1.14","volume":"2003","author":"GF Atweh","year":"2003","unstructured":"Atweh GF, DeSimone J, Saunthararajah Y, Fathallah H, Weinberg RS, Nagel RL, Fabry ME, Adams RJ (2003) Hemoglobinopathies. Hematology 2003(1):14\u201339","journal-title":"Hematology"},{"issue":"1","key":"1671_CR19","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1182\/asheducation-2009.1.54","volume":"2009","author":"KI Ataga","year":"2009","unstructured":"Ataga KI (2009) Novel therapies in sickle cell disease. Hematology 2009(1):54\u201361","journal-title":"Hematology"},{"issue":"11","key":"1671_CR20","doi-asserted-by":"crossref","first-page":"2341","DOI":"10.1016\/j.biocel.2008.04.024","volume":"40","author":"AR Migliaccio","year":"2008","unstructured":"Migliaccio AR, Rotili D, Nebbioso A, Atweh G, Mai A (2008) Histone deacetylase inhibitors and hemoglobin F induction in \u03b2-thalassemia. Int J Biochem Cell Biol 40(11):2341\u20132347","journal-title":"Int J Biochem Cell Biol"},{"key":"1671_CR21","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1017\/CBO9780511596582.041","volume-title":"Disorders of hemoglobin","author":"Y Saunthararajah","year":"2009","unstructured":"Saunthararajah Y, Atweh GF (2009) Induction of fetal hemoglobin in the treatment of sickle cell disease and \u03b2 thalassemia. In: Steinberg MH, Forget BG, Higgs DR, Weatherall DJ (eds) Disorders of hemoglobin, 2nd edn. Cambridge University Press, New York, pp 745\u2013754","edition":"2"},{"issue":"8","key":"1671_CR22","first-page":"1559","volume":"28","author":"IH Krakoff","year":"1968","unstructured":"Krakoff IH, Brown NC, Reichard P (1968) Inhibition of ribonucleoside diphosphate reductase by hydroxyurea. Cancer Res 28(8):1559\u20131565","journal-title":"Cancer Res"},{"issue":"10","key":"1671_CR23","doi-asserted-by":"crossref","first-page":"2555","DOI":"10.1182\/blood.V79.10.2555.2555","volume":"79","author":"S Charache","year":"1992","unstructured":"Charache S, Dover GJ, Moore RD, Eckert S, Ballas SK, Koshy M, Milner PF, Orringer EP, Phillips G Jr, Platt OS (1992) Hydroxyurea: effects on hemoglobin F production in patients with sickle cell anemia. Blood 79(10):2555\u20132565","journal-title":"Blood"},{"issue":"3","key":"1671_CR24","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1182\/blood.V89.3.1078","volume":"89","author":"MH Steinberg","year":"1997","unstructured":"Steinberg MH, Lu Z-H, Barton FB, Terrin ML, Charache S, Dover GJ, the Multicenter Study of H (1997) Fetal hemoglobin in sickle cell anemia: determinants of response to hydroxyurea. Blood 89(3):1078\u20131088","journal-title":"Blood"},{"key":"1671_CR25","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1100\/tsw.2002.295","volume":"2","author":"MH Steinberg","year":"2002","unstructured":"Steinberg MH (2002) Hydroxyurea treatment for sickle cell disease. Sci World J 2:1706\u20131728","journal-title":"Sci World J"},{"issue":"13","key":"1671_CR26","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1056\/NEJMct0708272","volume":"358","author":"OS Platt","year":"2008","unstructured":"Platt OS (2008) Hydroxyurea for the treatment of sickle cell anemia. N Engl J Med 358(13):1362\u20131369","journal-title":"N Engl J Med"},{"issue":"1","key":"1671_CR27","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.bcmd.2008.08.003","volume":"42","author":"K Italia","year":"2009","unstructured":"Italia K, Jain D, Gattani S, Jijina F, Nadkarni A, Sawant P, Nair S, Mohanty D, Ghosh K, Colah R (2009) Hydroxyurea in sickle cell disease-a study of clinico-pharmacological efficacy in the Indian haplotype. Blood Cells Mol Dis 42(1):25\u201331","journal-title":"Blood Cells Mol Dis"},{"issue":"3","key":"1671_CR28","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1111\/j.1365-2141.1995.tb05584.x","volume":"90","author":"YT Zeng","year":"1995","unstructured":"Zeng YT, Huang SZ, Ren ZR, Lu ZH, Zeng FY, Schechter AN, Rodgers GP (1995) Hydroxyurea therapy in \u03b2-thalassaemia intermedia: improvement in haematological parameters due to enhanced \u03b2-globin synthesis. Br J Haematol 90(3):557\u2013563","journal-title":"Br J Haematol"},{"issue":"3","key":"1671_CR29","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1182\/blood.V87.3.887.bloodjournal873887","volume":"87","author":"S Fucharoen","year":"1996","unstructured":"Fucharoen S, Siritanaratkul N, Winichagoon P, Chowthaworn J, Siriboon W, Muangsup W, Chaicharoen S, Poolsup N, Chindavijak B, Pootrakul P, Piankijagum A, Schechter AN, Rodgers GP (1996) Hydroxyurea increases hemoglobin F levels and improves the effectiveness of erythropoiesis in \u03b2-thalassemia\/hemoglobin E disease. Blood 87(3):887\u2013892","journal-title":"Blood"},{"issue":"4","key":"1671_CR30","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1182\/blood-2003-01-0117","volume":"102","author":"M Bradai","year":"2003","unstructured":"Bradai M, Abad MT, Pissard S, Lamraoui F, Skopinski L, de Montalembert M (2003) Hydroxyurea can eliminate transfusion requirements in children with severe \u03b2-thalassemia. Blood 102(4):1529\u20131530","journal-title":"Blood"},{"issue":"7","key":"1671_CR31","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1007\/s00277-003-0836-5","volume":"83","author":"M Alebouyeh","year":"2004","unstructured":"Alebouyeh M, Moussavi F, Haddad-Deylami H, Vossough P (2004) Hydroxyurea in the treatment of major \u03b2-thalassemia and importance of genetic screening. Ann Hematol 83(7):430\u2013433","journal-title":"Ann Hematol"},{"issue":"10","key":"1671_CR32","first-page":"1172","volume":"89","author":"M Yavarian","year":"2004","unstructured":"Yavarian M, Karimi M, Bakker E, Harteveld CL, Giordano PC (2004) Response to hydroxyurea treatment in Iranian transfusion-dependent \u03b2-thalassemia patients. Haematologica 89(10):1172\u20131178","journal-title":"Haematologica"},{"issue":"7","key":"1671_CR33","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1007\/s00277-005-1026-4","volume":"84","author":"A Dixit","year":"2005","unstructured":"Dixit A, Chatterjee TC, Mishra P, Choudhry DR, Mahapatra M, Tyagi S, Kabra M, Saxena R, Choudhry VP (2005) Hydroxyurea in thalassemia intermedia-a promising therapy. Ann Hematol 84(7):441\u2013446","journal-title":"Ann Hematol"},{"issue":"12","key":"1671_CR34","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1016\/j.exphem.2005.09.006","volume":"33","author":"Y Watanapokasin","year":"2005","unstructured":"Watanapokasin Y, Chuncharunee S, Sanmund D, Kongnium W, Winichagoon P, Rodgers GP, Fucharoen S (2005) In vivo and in vitro studies of fetal hemoglobin induction by hydroxyurea in \u03b2-thalassemia\/hemoglobin E patients. Exp Hematol 33(12):1486\u20131492","journal-title":"Exp Hematol"},{"issue":"3","key":"1671_CR35","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1007\/s00277-005-0049-1","volume":"85","author":"R Watanapokasin","year":"2006","unstructured":"Watanapokasin R, Sanmund D, Winichagoon P, Muta K, Fucharoen S (2006) Hydroxyurea responses and fetal hemoglobin induction in \u03b2-thalassemia\/HbE patients\u2019 peripheral blood erythroid cell culture. Ann Hematol 85(3):164\u2013169","journal-title":"Ann Hematol"},{"issue":"10","key":"1671_CR36","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1111\/j.1537-2995.2007.01399.x","volume":"47","author":"M Bradai","year":"2007","unstructured":"Bradai M, Pissard S, Abad MT, Dechartres A, Ribeil JA, Landais P, de Montalembert M (2007) Decreased transfusion needs associated with hydroxyurea therapy in Algerian patients with thalassemia major or intermedia. Transfusion 47(10):1830\u20131836","journal-title":"Transfusion"},{"issue":"11","key":"1671_CR37","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1097\/MPH.0b013e318157fd75","volume":"29","author":"SH Ansari","year":"2007","unstructured":"Ansari SH, Shamsi TS, Siddiqui FJ, Irfan M, Perveen K, Farzana T, Panjwani VK, Yousuf A, Mehboob T (2007) Efficacy of hydroxyurea (HU) in reduction of pack red cell (PRC) transfusion requirement among children having \u03b2-thalassemia major: Karachi HU trial (KHUT). J Pediatr Hematol Oncol 29(11):743\u2013746","journal-title":"J Pediatr Hematol Oncol"},{"issue":"5","key":"1671_CR38","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1002\/ajh.21120","volume":"83","author":"A Koren","year":"2008","unstructured":"Koren A, Levin C, Dgany O, Kransnov T, Elhasid R, Zalman L, Palmor H, Tamary H (2008) Response to hydroxyurea therapy in \u03b2-thalassemia. Am J Hematol 83(5):366\u2013370","journal-title":"Am J Hematol"},{"issue":"1\u20132","key":"1671_CR39","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.cca.2009.06.019","volume":"407","author":"KY Italia","year":"2009","unstructured":"Italia KY, Jijina FJ, Merchant R, Panjwani S, Nadkarni AH, Sawant PM, Nair SB, Ghosh K, Colah RB (2009) Response to hydroxyurea in \u03b2 thalassemia major and intermedia: experience in western India. Clin Chim Acta 407(1\u20132):10\u201315","journal-title":"Clin Chim Acta"},{"issue":"1","key":"1671_CR40","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s12185-011-0985-6","volume":"95","author":"M Karimi","year":"2012","unstructured":"Karimi M, Haghpanah S, Farhadi A, Yavarian M (2012) Genotype-phenotype relationship of patients with \u03b2-thalassemia taking hydroxyurea: a 13-year experience in Iran. Int J Hematol 95(1):51\u201356","journal-title":"Int J Hematol"},{"issue":"4","key":"1671_CR41","doi-asserted-by":"crossref","first-page":"371","DOI":"10.3109\/03630269.2012.691147","volume":"36","author":"M Banan","year":"2012","unstructured":"Banan M, Bayat H, Azarkeivan A, Mohammadparast S, Kamali K, Farashi S, Bayat N, Khani MH, Neishabury M, Najmabadi H (2012) The XmnI and BCL11A single nucleotide polymorphisms may help predict hydroxyurea response in Iranian \u03b2-thalassemia patients. Hemoglobin 36(4):371\u2013380","journal-title":"Hemoglobin"},{"issue":"5","key":"1671_CR42","first-page":"1550","volume":"94","author":"TR Kinney","year":"1999","unstructured":"Kinney TR, Helms RW, O\u2019Branski EE, Ohene-Frempong K, Wang W, Daeschner C, Vichinsky E, Redding-Lallinger R, Gee B, Platt OS, Ware RE (1999) Safety of hydroxyurea in children with sickle cell anemia: results of the HUG-KIDS study, a phase I\/II Trial. Blood 94(5):1550\u20131554","journal-title":"Blood"},{"issue":"3","key":"1671_CR43","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1097\/MOH.0b013e32834521dd","volume":"18","author":"PT McGann","year":"2011","unstructured":"McGann PT, Ware RE (2011) Hydroxyurea for sickle cell anemia: what have we learned and what questions still remain? Curr Opin Hematol 18(3):158\u2013165","journal-title":"Curr Opin Hematol"},{"issue":"13","key":"1671_CR44","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1001\/jama.289.13.1645","volume":"289","author":"MH Steinberg","year":"2003","unstructured":"Steinberg MH, Barton F, Castro O, Pegelow CH, Ballas SK, Kutlar A, Orringer E, Bellevue R, Olivieri N, Eckman J, Varma M, Ramirez G, Adler B, Smith W, Carlos T, Ataga K, DeCastro L, Bigelow C, Saunthararajah Y, Telfer M, Vichinsky E, Claster S, Shurin S, Bridges K, Waclawiw M, Bonds D, Terrin M (2003) Effect of hydroxyurea on mortality and morbidity in adult sickle cell anemia: risks and benefits up to 9 years of treatment. JAMA 289(13):1645\u20131651","journal-title":"JAMA"},{"issue":"12","key":"1671_CR45","doi-asserted-by":"crossref","first-page":"939","DOI":"10.7326\/0003-4819-148-12-200806170-00221","volume":"148","author":"S Lanzkron","year":"2008","unstructured":"Lanzkron S, Strouse JJ, Wilson R, Beach MC, Haywood C, Park H, Witkop C, Bass EB, Segal JB (2008) Systematic review: hydroxyurea for the treatment of adults with sickle cell disease. Ann Intern Med 148(12):939\u2013955","journal-title":"Ann Intern Med"},{"issue":"11","key":"1671_CR46","doi-asserted-by":"crossref","first-page":"3589","DOI":"10.1182\/blood.V95.11.3589","volume":"95","author":"VN Hanft","year":"2000","unstructured":"Hanft VN, Fruchtman SR, Pickens CV, Rosse WF, Howard TA, Ware RE (2000) Acquired DNA mutations associated with in vivo hydroxyurea exposure. Blood 95(11):3589\u20133593","journal-title":"Blood"},{"key":"1671_CR47","doi-asserted-by":"crossref","unstructured":"Pourfarzad F, von Lindern M, Azarkeivan A, Hou J, Kheradmand Kia S, Esteghamat F, van Ijcken W, Philipsen S, Najmabadi H, Grosveld F (2013) Hydroxyurea responsiveness in \u03b2-thalassemic patients is determined by the stress response adaptation of erythroid progenitors and their differentiation propensity. Haematologica (in press)","DOI":"10.3324\/haematol.2012.074492"},{"issue":"9","key":"1671_CR48","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1016\/j.exphem.2008.06.014","volume":"36","author":"R Mabaera","year":"2008","unstructured":"Mabaera R, West RJ, Conine SJ, Macari ER, Boyd CD, Engman CA, Lowrey CH (2008) A cell stress signaling model of fetal hemoglobin induction: what doesn\u2019t kill red blood cells may make them stronger. Exp Hematol 36(9):1057\u20131072","journal-title":"Exp Hematol"},{"key":"1671_CR49","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1017\/CBO9780511596582.006","volume-title":"Disorders of hemoglobin","author":"S Philipsen","year":"2009","unstructured":"Philipsen S, Wood WG (2009) Erythropoiesis. In: Steinberg MH, Forget BG, Higgs DR, Weatherall DJ (eds) Disorders of hemoglobin, 2nd edn. Cambridge University Press, Cambridge, pp 24\u201345","edition":"2"},{"issue":"14","key":"1671_CR50","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1056\/NEJM198404053101401","volume":"310","author":"NL Letvin","year":"1984","unstructured":"Letvin NL, Linch DC, Beardsley GP, McIntyre KW, Nathan DG (1984) Augmentation of fetal-hemoglobin production in anemic monkeys by hydroxyurea. N Engl J Med 310(14):869\u2013873","journal-title":"N Engl J Med"},{"issue":"6","key":"1671_CR51","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1172\/JCI111918","volume":"75","author":"NL Letvin","year":"1985","unstructured":"Letvin NL, Linch DC, Beardsley GP, McIntyre KW, Miller BA, Nathan DG (1985) Influence of cell cycle phase-specific agents on simian fetal hemoglobin synthesis. J Clin Invest 75(6):1999\u20132005","journal-title":"J Clin Invest"},{"issue":"6","key":"1671_CR52","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1182\/blood.V70.6.1824.1824","volume":"70","author":"BA Miller","year":"1987","unstructured":"Miller BA, Platt O, Hope S, Dover G, Nathan DG (1987) Influence of hydroxyurea on fetal hemoglobin production in vitro. Blood 70(6):1824\u20131829","journal-title":"Blood"},{"issue":"4","key":"1671_CR53","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1002\/ajh.2830460402","volume":"46","author":"VN Mankad","year":"1994","unstructured":"Mankad VN, Baliga S, Phillips K, Shah AK, Yang YM (1994) Relationship of burst-forming-unit-erythroid progenitors and their DNA-synthesis stage to fetal hemoglobin levels in hydroxyurea-treated patients with sickle cell anemia. Am J Hematol 46(4):259\u2013263","journal-title":"Am J Hematol"},{"issue":"2","key":"1671_CR54","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1111\/j.1365-2141.2012.09061.x","volume":"157","author":"JM Flanagan","year":"2012","unstructured":"Flanagan JM, Steward S, Howard TA, Mortier NA, Kimble AC, Aygun B, Hankins JS, Neale GA, Ware RE (2012) Hydroxycarbamide alters erythroid gene expression in children with sickle cell anaemia. Br J Haematol 157(2):240\u2013248","journal-title":"Br J Haematol"},{"issue":"4","key":"1671_CR55","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1046\/j.1365-2141.2002.03958.x","volume":"119","author":"M Wang","year":"2002","unstructured":"Wang M, Tang DC, Liu W, Chin K, Zhu JG, Fibach E, Rodgers GP (2002) Hydroxyurea exerts bi-modal dose-dependent effects on erythropoiesis in human cultured erythroid cells via distinct pathways. Br J Haematol 119(4):1098\u20131105","journal-title":"Br J Haematol"},{"issue":"21","key":"1671_CR56","doi-asserted-by":"crossref","first-page":"9623","DOI":"10.1073\/pnas.92.21.9623","volume":"92","author":"MJ Weiss","year":"1995","unstructured":"Weiss MJ, Orkin SH (1995) Transcription factor GATA-1 permits survival and maturation of erythroid precursors by preventing apoptosis. Proc Natl Acad Sci USA 92(21):9623\u20139627","journal-title":"Proc Natl Acad Sci USA"},{"issue":"12","key":"1671_CR57","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1016\/j.leukres.2004.03.022","volume":"28","author":"HG Drexler","year":"2004","unstructured":"Drexler HG, Matsuo Y, MacLeod RA (2004) Malignant hematopoietic cell lines: in vitro models for the study of erythroleukemia. Leuk Res 28(12):1243\u20131251","journal-title":"Leuk Res"},{"issue":"6","key":"1671_CR58","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1182\/blood.V58.6.1236.1236","volume":"58","author":"F Erard","year":"1981","unstructured":"Erard F, Dean A, Schechter AN (1981) Inhibitors of cell division reversibly modify hemoglobin concentration in human erythroleukemia K562 cells. Blood 58(6):1236\u20131239","journal-title":"Blood"},{"issue":"9","key":"1671_CR59","doi-asserted-by":"crossref","first-page":"3256","DOI":"10.1182\/blood-2003-10-3458","volume":"106","author":"DC Tang","year":"2005","unstructured":"Tang DC, Zhu J, Liu W, Chin K, Sun J, Chen L, Hanover JA, Rodgers GP (2005) The hydroxyurea-induced small GTP-binding protein SAR modulates \u03b3-globin gene expression in human erythroid cells. Blood 106(9):3256\u20133263","journal-title":"Blood"},{"issue":"6","key":"1671_CR60","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1182\/blood.V81.6.1630.1630","volume":"81","author":"E Fibach","year":"1993","unstructured":"Fibach E, Burke KP, Schechter AN, Noguchi CT, Rodgers GP (1993) Hydroxyurea increases fetal hemoglobin in cultured erythroid cells derived from normal individuals and patients with sickle cell anemia or \u03b2-thalassemia. Blood 81(6):1630\u20131635","journal-title":"Blood"},{"issue":"3","key":"1671_CR61","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1182\/blood.V95.3.863.003k12_863_869","volume":"95","author":"RD Smith","year":"2000","unstructured":"Smith RD, Li J, Noguchi CT, Schechter AN (2000) Quantitative PCR analysis of HbF inducers in primary human adult erythroid cells. Blood 95(3):863\u2013869","journal-title":"Blood"},{"issue":"4","key":"1671_CR62","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.exphem.2011.01.004","volume":"39","author":"AL Walker","year":"2011","unstructured":"Walker AL, Franke RM, Sparreboom A, Ware RE (2011) Transcellular movement of hydroxyurea is mediated by specific solute carrier transporters. Exp Hematol 39(4):446\u2013456","journal-title":"Exp Hematol"},{"issue":"9005","key":"1671_CR63","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1016\/S0140-6736(96)91378-1","volume":"347","author":"R Pacelli","year":"1996","unstructured":"Pacelli R, Taira J, Cook JA, Wink DA, Krishna MC (1996) Hydroxyurea reacts with heme proteins to generate nitric oxide. Lancet 347(9005):900","journal-title":"Lancet"},{"issue":"3","key":"1671_CR64","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1182\/blood-2007-05-088732","volume":"111","author":"VP Cokic","year":"2008","unstructured":"Cokic VP, Andric SA, Stojilkovic SS, Noguchi CT, Schechter AN (2008) Hydroxyurea nitrosylates and activates soluble guanylyl cyclase in human erythroid cells. Blood 111(3):1117\u20131123","journal-title":"Blood"},{"issue":"2","key":"1671_CR65","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1172\/JCI200316672","volume":"111","author":"VP Cokic","year":"2003","unstructured":"Cokic VP, Smith RD, Beleslin-Cokic BB, Njoroge JM, Miller JL, Gladwin MT, Schechter AN (2003) Hydroxyurea induces fetal hemoglobin by the nitric oxide-dependent activation of soluble guanylyl cyclase. J Clin Invest 111(2):231\u2013239","journal-title":"J Clin Invest"},{"issue":"4","key":"1671_CR66","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1073\/pnas.98.4.1847","volume":"98","author":"T Ikuta","year":"2001","unstructured":"Ikuta T, Ausenda S, Cappellini MD (2001) Mechanism for fetal globin gene expression: role of the soluble guanylate cyclase-cGMP-dependent protein kinase pathway. Proc Natl Acad Sci USA 98(4):1847\u20131852","journal-title":"Proc Natl Acad Sci USA"},{"key":"1671_CR67","doi-asserted-by":"crossref","unstructured":"Cokic VP, Schechter AN (2008) Effects of nitric oxide on red blood cell development and phenotype. In: Bieker JJ (ed) Red cell development, vol. 82. Elsevier, Amsterdam, pp. 169\u2013200","DOI":"10.1016\/S0070-2153(07)00007-5"},{"issue":"3","key":"1671_CR68","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/0303-7207(82)90135-6","volume":"28","author":"JA Beavo","year":"1982","unstructured":"Beavo JA, Hansen RS, Harrison SA, Hurwitz RL, Martins TJ, Mumby MC (1982) Identification and properties of cyclic nucleotide phosphodiesterases. Mol Cell Endocrinol 28(3):387\u2013410","journal-title":"Mol Cell Endocrinol"},{"issue":"9","key":"1671_CR69","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1016\/j.exphem.2006.03.018","volume":"34","author":"JR Keefer","year":"2006","unstructured":"Keefer JR, Schneidereith TA, Mays A, Purvis SH, Dover GJ, Smith KD (2006) Role of cyclic nucleotides in fetal hemoglobin induction in cultured CD34+ cells. Exp Hematol 34(9):1151\u20131161","journal-title":"Exp Hematol"},{"issue":"3","key":"1671_CR70","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1016\/j.bbrc.2006.03.203","volume":"344","author":"Y Kuroyanagi","year":"2006","unstructured":"Kuroyanagi Y, Kaneko Y, Muta K, Park BS, Moi P, Ausenda S, Cappellini MD, Ikuta T (2006) cAMP differentially regulates \u03b3-globin gene expression in erythroleukemic cells and primary erythroblasts through c-Myb expression. Biochem Biophys Res Commun 344(3):1038\u20131047","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"1671_CR71","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.bcmd.2011.03.003","volume":"47","author":"V Ramakrishnan","year":"2011","unstructured":"Ramakrishnan V, Pace BS (2011) Regulation of \u03b3-globin gene expression involves signaling through the p38 MAPK\/CREB1 pathway. Blood Cells Mol Dis 47(1):12\u201322","journal-title":"Blood Cells Mol Dis"},{"issue":"9","key":"1671_CR72","first-page":"481","volume":"12","author":"J-I Park","year":"2001","unstructured":"Park J-I, Choi H-S, Jeong J-S, Han J-Y, Kim I-H (2001) Involvement of p38 kinase in hydroxyurea-induced differentiation of K562 cells. Cell Growth Differ 12(9):481\u2013486","journal-title":"Cell Growth Differ"},{"issue":"10","key":"1671_CR73","doi-asserted-by":"crossref","first-page":"3590","DOI":"10.1182\/blood-2006-01-023713","volume":"108","author":"J Sangerman","year":"2006","unstructured":"Sangerman J, Lee MS, Yao X, Oteng E, Hsiao C-H, Li W, Zein S, Ofori-Acquah SF, Pace BS (2006) Mechanism for fetal hemoglobin induction by histone deacetylase inhibitors involves \u03b3-globin activation by CREB1 and ATF-2. Blood 108(10):3590\u20133599","journal-title":"Blood"},{"issue":"1","key":"1671_CR74","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.bcmd.2009.10.002","volume":"44","author":"S Kodeboyina","year":"2010","unstructured":"Kodeboyina S, Balamurugan P, Liu L, Pace BS (2010) cJun modulates G\u03b3-globin gene expression via an upstream cAMP response element. Blood Cells Mol Dis 44(1):7\u201315","journal-title":"Blood Cells Mol Dis"},{"issue":"6","key":"1671_CR75","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1111\/j.1440-1681.2012.05702.x","volume":"39","author":"M Banan","year":"2012","unstructured":"Banan M, Esmaeilzadeh-Ghar E, Nezami M, Deilami Z, Farashi S, Philipsen S, Esteghamat F, Pourfarzad F, Ali Imam AM, Najmabadi H (2012) cAMP response element-binding protein 1 is required for hydroxyurea-mediated induction of \u03b3-globin expression in K562 cells. Clin Exp Pharmacol Physiol 39(6):510\u2013517","journal-title":"Clin Exp Pharmacol Physiol"},{"issue":"5","key":"1671_CR76","doi-asserted-by":"crossref","first-page":"441","DOI":"10.2174\/1389201043376643","volume":"5","author":"M Banan","year":"2004","unstructured":"Banan M, Puri N (2004) The ins and outs of RNAi in mammalian cells. Curr Pharm Biotechnol 5(5):441\u2013450","journal-title":"Curr Pharm Biotechnol"},{"issue":"20","key":"1671_CR77","doi-asserted-by":"crossref","first-page":"5664","DOI":"10.1182\/blood-2011-07-368746","volume":"118","author":"AL Walker","year":"2011","unstructured":"Walker AL, Steward S, Howard TA, Mortier N, Smeltzer M, Wang Y-D, Ware RE (2011) Epigenetic and molecular profiles of erythroid cells after hydroxyurea treatment in sickle cell anemia. Blood 118(20):5664\u20135670","journal-title":"Blood"},{"issue":"2","key":"1671_CR78","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1002\/pbc.22754","volume":"56","author":"NS Green","year":"2010","unstructured":"Green NS, Barral S (2010) Genetic modifiers of HbF and response to hydroxyurea in sickle cell disease. Pediatr Blood Cancer 56(2):177\u2013181","journal-title":"Pediatr Blood Cancer"},{"issue":"3","key":"1671_CR79","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1097\/MOH.0b013e328329d07a","volume":"16","author":"S Menzel","year":"2009","unstructured":"Menzel S, Thein SL (2009) Genetic architecture of hemoglobin F control. Curr Opin Hematol 16(3):179\u2013186","journal-title":"Curr Opin Hematol"},{"issue":"6","key":"1671_CR80","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1182\/blood.V66.6.1463.1463","volume":"66","author":"D Labie","year":"1985","unstructured":"Labie D, Dunda-Belkhodja O, Rouabhi F, Pagnier J, Ragusa A, Nagel RL (1985) The \u2013158 site 5\u2032 to the G\u03b3 gene and G\u03b3 expression. Blood 66(6):1463\u20131465","journal-title":"Blood"},{"issue":"4","key":"1671_CR81","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1182\/blood.V66.4.783.783","volume":"66","author":"JG Gilman","year":"1985","unstructured":"Gilman JG, Huisman TH (1985) DNA sequence variation associated with elevated fetal G\u03b3 globin production. Blood 66(4):783\u2013787","journal-title":"Blood"},{"issue":"7","key":"1671_CR82","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1073\/pnas.82.7.2111","volume":"82","author":"D Labie","year":"1985","unstructured":"Labie D, Pagnier J, Lapoumeroulie C, Rouabhi F, Dunda-Belkhodja O, Chardin P, Beldjord C, Wajcman H, Fabry ME, Nagel RL (1985) Common haplotype dependency of high G\u03b3-globin gene expression and high Hb F levels in \u03b2-thalassemia and sickle cell anemia patients. Proc Natl Acad Sci USA 82(7):2111\u20132114","journal-title":"Proc Natl Acad Sci USA"},{"issue":"33","key":"1671_CR83","doi-asserted-by":"crossref","first-page":"11869","DOI":"10.1073\/pnas.0804799105","volume":"105","author":"G Lettre","year":"2008","unstructured":"Lettre G, Sankaran VG, Bezerra MAC, Araujo AS, Uda M, Sanna S, Cao A, Schlessinger D, Costa FF, Hirschhorn JN, Orkin SH (2008) DNA polymorphisms at the BCL11A, HBS1L-MYB, and \u03b2-globin loci associate with fetal hemoglobin levels and pain crises in sickle cell disease. Proc Natl Acad Sci USA 105(33):11869\u201311874","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"1671_CR84","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1182\/blood.V95.1.342","volume":"95","author":"C Garner","year":"2000","unstructured":"Garner C, Tatu T, Reittie JE, Littlewood T, Darley J, Cervino S, Farrall M, Kelly P, Spector TD, Thein SL (2000) Genetic influences on F cells and other hematologic variables: a twin heritability study. Blood 95(1):342\u2013346","journal-title":"Blood"},{"issue":"11","key":"1671_CR85","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.3324\/haematol.2011.046748","volume":"96","author":"C Badens","year":"2011","unstructured":"Badens C, Joly P, Agouti I, Thuret I, Gonnet K, Fattoum S, Francina A, Simeoni M-C, Loundou A, Pissard S (2011) Variants in genetic modifiers of \u03b2-thalassemia can help to predict the major or intermedia type of the disease. Haematologica 96(11):1712\u20131714","journal-title":"Haematologica"},{"issue":"11","key":"1671_CR86","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.3324\/haematol.2011.055962","volume":"96","author":"F Danjou","year":"2011","unstructured":"Danjou F, Anni F, Galanello R (2011) \u03b2-thalassemia: from genotype to phenotype. Haematologica 96(11):1573\u20131575","journal-title":"Haematologica"},{"key":"1671_CR87","doi-asserted-by":"crossref","unstructured":"Banan M, Bayat H, Namdar P, Azarkeivan A, Kamali K, Daneshmand P, Zaker B, Najmabadi H (2013) Utility of the multivariate approach in predicting the \u03b2-thalassemia intermedia or major types in Iranian patients. Hemoglobin (in press)","DOI":"10.3109\/03630269.2013.805418"},{"issue":"3","key":"1671_CR88","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1046\/j.1365-2141.2003.04769.x","volume":"124","author":"SL Thein","year":"2004","unstructured":"Thein SL (2004) Genetic insights into the clinical diversity of \u03b2 thalassaemia. Br J Haematol 124(3):264\u2013274","journal-title":"Br J Haematol"},{"issue":"5909","key":"1671_CR89","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1126\/science.1165409","volume":"322","author":"VG Sankaran","year":"2008","unstructured":"Sankaran VG, Menne TF, Xu J, Akie TE, Lettre G, Van Handel B, Mikkola HKA, Hirschhorn JN, Cantor AB, Orkin SH (2008) Human fetal hemoglobin expression is regulated by the developmental stage-specific repressor BCL11A. Science 322(5909):1839\u20131842","journal-title":"Science"},{"issue":"2","key":"1671_CR90","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.bcmd.2008.12.003","volume":"42","author":"Z Chen","year":"2009","unstructured":"Chen Z, Luo HY, Steinberg MH, Chui DH (2009) BCL11A represses HBG transcription in K562 cells. Blood Cells Mol Dis 42(2):144\u2013149","journal-title":"Blood Cells Mol Dis"},{"issue":"7259","key":"1671_CR91","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1038\/nature08243","volume":"460","author":"VG Sankaran","year":"2009","unstructured":"Sankaran VG, Xu J, Ragoczy T, Ippolito GC, Walkley CR, Maika SD, Fujiwara Y, Ito M, Groudine M, Bender MA, Tucker PW, Orkin SH (2009) Developmental and species-divergent globin switching are driven by BCL11A. Nature 460(7259):1093\u20131097","journal-title":"Nature"},{"issue":"6058","key":"1671_CR92","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1126\/science.1211053","volume":"334","author":"J Xu","year":"2011","unstructured":"Xu J, Peng C, Sankaran VG, Shao Z, Esrick EB, Chong BG, Ippolito GC, Fujiwara Y, Ebert BL, Tucker PW, Orkin SH (2011) Correction of sickle cell disease in adult mice by interference with fetal hemoglobin silencing. Science 334(6058):993\u2013996","journal-title":"Science"},{"issue":"5","key":"1671_CR93","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1073\/pnas.0711566105","volume":"105","author":"M Uda","year":"2008","unstructured":"Uda M, Galanello R, Sanna S, Lettre G, Sankaran VG, Chen W, Usala G, Busonero F, Maschio A, Albai G, Piras MG, Sestu N, Lai S, Dei M, Mulas A, Crisponi L, Naitza S, Asunis I, Deiana M, Nagaraja R, Perseu L, Satta S, Cipollina MD, Sollaino C, Moi P, Hirschhorn JN, Orkin SH, Abecasis GR, Schlessinger D, Cao A (2008) Genome-wide association study shows BCL11A associated with persistent fetal hemoglobin and amelioration of the phenotype of \u03b2-thalassemia. Proc Natl Acad Sci USA 105(5):1620\u20131625","journal-title":"Proc Natl Acad Sci USA"},{"issue":"12","key":"1671_CR94","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1038\/ng.707","volume":"42","author":"G Galarneau","year":"2010","unstructured":"Galarneau G, Palmer CD, Sankaran VG, Orkin SH, Hirschhorn JN, Lettre G (2010) Fine-mapping at three loci known to affect fetal hemoglobin levels explains additional genetic variation. Nat Genet 42(12):1049\u20131051","journal-title":"Nat Genet"},{"issue":"2","key":"1671_CR95","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.bcmd.2010.04.002","volume":"45","author":"TK Nguyen","year":"2010","unstructured":"Nguyen TK, Joly P, Bardel C, Moulsma M, Bonello-Palot N, Francina A (2010) The XmnI G\u03b3 polymorphism influences hemoglobin F synthesis contrary to BCL11A and HBS1L-MYB SNPs in a cohort of 57 \u03b2-thalassemia intermedia patients. Blood Cells Mol Dis 45(2):124\u2013127","journal-title":"Blood Cells Mol Dis"},{"issue":"3","key":"1671_CR96","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.bcmd.2008.06.007","volume":"41","author":"AE Sedgewick","year":"2008","unstructured":"Sedgewick AE, Timofeev N, Sebastiani P, So JC, Ma ES, Chan LC, Fucharoen G, Fucharoen S, Barbosa CG, Vardarajan BN, Farrer LA, Baldwin CT, Steinberg MH, Chui DH (2008) BCL11A is a major HbF quantitative trait locus in three different populations with \u03b2-hemoglobinopathies. Blood Cells Mol Dis 41(3):255\u2013258","journal-title":"Blood Cells Mol Dis"},{"issue":"4","key":"1671_CR97","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1038\/jhg.2011.12","volume":"56","author":"P Bhatnagar","year":"2011","unstructured":"Bhatnagar P, Purvis S, Barron-Casella E, DeBaun MR, Casella JF, Arking DE, Keefer JR (2011) Genome-wide association study identifies genetic variants influencing F-cell levels in sickle-cell patients. J Hum Genet 56(4):316\u2013323","journal-title":"J Hum Genet"},{"key":"1671_CR98","doi-asserted-by":"crossref","unstructured":"Galanello R, Sanna S, Perseu L, Sollaino MC, Satta S, Lai ME, Barella S, Uda M, Usala G, Abecasis GR, Cao A (2009) Amelioration of Sardinian \u03b2o thalassemia by genetic modifiers. Blood 114(18):3935\u20133937","DOI":"10.1182\/blood-2009-04-217901"},{"issue":"21","key":"1671_CR99","first-page":"2148","volume":"118","author":"DE Bauer","year":"2011","unstructured":"Bauer DE, Xu J, Fujiwara Y, Stamatoyannopoulos JA, Orkin SH (2011) Functional evaluation of HbF-associated region of BCL11A locus. Blood (ASH Annual Meeting Abstracts) 118(21):2148","journal-title":"Blood (ASH Annual Meeting Abstracts)"},{"issue":"6","key":"1671_CR100","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1182\/blood-2009-03-210146","volume":"114","author":"K Wahlberg","year":"2009","unstructured":"Wahlberg K, Jiang J, Rooks H, Jawaid K, Matsuda F, Yamaguchi M, Lathrop M, Thein SL, Best S (2009) The HBS1L-MYB intergenic interval associated with elevated HbF levels shows characteristics of a distal regulatory region in erythroid cells. Blood 114(6):1254\u20131262","journal-title":"Blood"},{"issue":"1","key":"1671_CR101","doi-asserted-by":"crossref","first-page":"e4218","DOI":"10.1371\/journal.pone.0004218","volume":"4","author":"LE Creary","year":"2009","unstructured":"Creary LE, Ulug P, Menzel S, McKenzie CA, Hanchard NA, Taylor V, Farrall M, Forrester TE, Thein SL (2009) Genetic variation on chromosome 6 influences F cell levels in healthy individuals of African descent and HbF levels in sickle cell patients. PLoS One 4(1):e4218","journal-title":"PLoS One"},{"issue":"3","key":"1671_CR102","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1182\/blood-2006-01-008912","volume":"108","author":"J Jiang","year":"2006","unstructured":"Jiang J, Best S, Menzel S, Silver N, Lai MI, Surdulescu GL, Spector TD, Thein SL (2006) cMYB is involved in the regulation of fetal hemoglobin production in adults. Blood 108(3):1077\u20131083","journal-title":"Blood"},{"key":"1671_CR103","doi-asserted-by":"crossref","unstructured":"Sankaran VG, Menne TF, Scepanovic D, Vergilio J-A, Ji P, Kim J, Thiru P, Orkin SH, Lander ES, Lodish HF (2011) MicroRNA-15a and -16-1 act via MYB to elevate fetal hemoglobin expression in human trisomy 13. Proc Natl Acad Sci USA 108(4):1519\u20131524","DOI":"10.1073\/pnas.1018384108"},{"issue":"18","key":"1671_CR104","doi-asserted-by":"crossref","first-page":"4935","DOI":"10.1182\/blood-2010-11-317081","volume":"117","author":"JJ Farrell","year":"2011","unstructured":"Farrell JJ, Sherva RM, Chen Z-y, Luo H-y, Chu BF, Ha SY, Li CK, Lee ACW, Li RCH, Li CK, Yuen HL, So JCC, Ma ESK, Chan LC, Chan V, Sebastiani P, Farrer LA, Baldwin CT, Steinberg MH, Chui DHK (2011) A 3-bp deletion in the HBS1L-MYB intergenic region on chromosome 6q23 is associated with HbF expression. Blood 117(18):4935\u20134945","journal-title":"Blood"},{"issue":"4","key":"1671_CR105","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1038\/emboj.2011.450","volume":"31","author":"R Stadhouders","year":"2012","unstructured":"Stadhouders R, Thongjuea S, Andrieu-Soler C, Palstra RJ, Bryne JC, van den Heuvel A, Stevens M, de Boer E, Kockx C, van der Sloot A, van den Hout M, van Ijcken W, Eick D, Lenhard B, Grosveld F, Soler E (2012) Dynamic long-range chromatin interactions control Myb proto-oncogene transcription during erythroid development. EMBO J 31(4):986\u2013999","journal-title":"EMBO J"},{"issue":"2","key":"1671_CR106","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1111\/j.1365-2141.2008.07045.x","volume":"141","author":"C Kumkhaek","year":"2008","unstructured":"Kumkhaek C, Taylor JG, Zhu J, Hoppe C, Kato GJ, Rodgers GP (2008) Fetal haemoglobin response to hydroxycarbamide treatment and sar1a promoter polymorphisms in sickle cell anaemia. Br J Haematol 141(2):254\u2013259","journal-title":"Br J Haematol"},{"issue":"6","key":"1671_CR107","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1038\/sj.tpj.6500433","volume":"7","author":"Q Ma","year":"2007","unstructured":"Ma Q, Wyszynski DF, Farrell JJ, Kutlar A, Farrer LA, Baldwin CT, Steinberg MH (2007) Fetal hemoglobin in sickle cell anemia: genetic determinants of response to hydroxyurea. Pharmacogenomics J 7(6):386\u2013394","journal-title":"Pharmacogenomics J"},{"issue":"18","key":"1671_CR108","doi-asserted-by":"crossref","first-page":"4985","DOI":"10.1182\/blood-2011-07-364190","volume":"118","author":"RE Ware","year":"2011","unstructured":"Ware RE, Despotovic JM, Mortier NA, Flanagan JM, He J, Smeltzer MP, Kimble AC, Aygun B, Wu S, Howard T, Sparreboom A (2011) Pharmacokinetics, pharmacodynamics, and pharmacogenetics of hydroxyurea treatment for children with sickle cell anemia. Blood 118(18):4985\u20134991","journal-title":"Blood"},{"issue":"2","key":"1671_CR109","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1111\/j.1365-2141.2011.08937.x","volume":"157","author":"N Vasavda","year":"2012","unstructured":"Vasavda N, Woodley C, Allman M, Drasar E, Awogbade M, Howard J, Thein SL (2012) Effects of co-existing \u03b1-thalassaemia in sickle cell disease on hydroxycarbamide therapy and circulating nucleic acids. Br J Haematol 157(2):249\u2013252","journal-title":"Br J Haematol"},{"issue":"4","key":"1671_CR110","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1096\/fj.11-199356","volume":"26","author":"KSK Chan","year":"2012","unstructured":"Chan KSK, Xu J, Wardan H, McColl B, Orkin S, Vadolas J (2012) Generation of a genomic reporter assay system for analysis of \u03b3- and \u03b2-globin gene regulation. FASEB J 26(4):1736\u20131744","journal-title":"FASEB J"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-012-1671-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00277-012-1671-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-012-1671-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,28]],"date-time":"2023-06-28T17:24:01Z","timestamp":1687973041000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00277-012-1671-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1,15]]},"references-count":110,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,3]]}},"alternative-id":["1671"],"URL":"https:\/\/doi.org\/10.1007\/s00277-012-1671-3","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,1,15]]}}}